Korea Bio-Gen Co.Ltd

318000 · KQ · Basic Materials / Specialty Chemicals

2,340.00KRW+45.00 (+1.96%)

Price History

Full chart

Market Stats

Previous Close2,295.00

Open2,315.00

Day Range2,300.00 – 2,340.00

52-Week Range2,545.00 – 6,055.48

Volume1.06K

Market Cap23.66B

P/E (TTM)0.00

Forward P/E0.00

Dividend Yield2.21%

Beta0.31

50-Day Avg2,817.30

200-Day Avg3,717.05

About

KBG Corp. produces and supplies a range of fine chemicals in South Korea and internationally. The company offers silicone chemicals, such as functional organosilanes, functional silicone polymers, silicone resins and intermediates, silicone pressure sensitive adhesives, and silicone materials for electronics; specialty chemicals, including polymerization inhibitors; and food additives, as well as silicon inorganic chemical materials, organic materials, bio-materials, and others. It serves electric and electronics, automobile, construction, chemical related industries of food and pharmaceuticals, petrochemicals, etc. The company was formerly known as Korea Bio-Gen Co.,Ltd. KBG Corp. was founded in 2001 and is headquartered in Cheonan-si, South Korea.

Company Details

SectorBasic Materials
IndustrySpecialty Chemicals
CEOSamuel Boo
Employees72
Headquarters84-19 Daeheungsindeok-Road, Cheonan-si, South Korea, 31248, Korea
Websitehttps://kbgtech.co.kr

Leadership

Samuel BooCEO & Director · b. 1986
TaeGyun BooSales Manager · b. 1966

Financials

Income Statement

Currency: KRW	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	14.41B	16.43B	18.53B	19.79B	27.20B	24.35B	21.59B	24.92B	23.92B
Growth (%)	-	+14.07%	+12.73%	+6.81%	+37.47%	-10.50%	-11.32%	+15.41%	-3.99%
Cost of Revenue	10.10B	11.56B	13.30B	13.71B	17.98B	16.99B	14.38B	16.92B	16.77B
Gross Profit	4.30B	4.87B	5.23B	6.08B	9.22B	7.36B	7.21B	8.00B	7.15B
Gross Margin	29.86%	29.64%	28.22%	30.70%	33.91%	30.23%	33.41%	32.09%	29.87%
Operating Expense	2.20B	2.00B	2.26B	2.66B	3.33B	3.26B	2.68B	3.97B	4.15B
Operating Income	2.10B	2.87B	2.97B	3.41B	5.89B	4.11B	4.53B	4.02B	2.99B
Operating Margin	14.57%	17.48%	16.01%	17.24%	21.65%	16.86%	21.00%	16.14%	12.51%
EBITDA	-	-	-	-	-	5.00B	6.59B	5.56B	4.64B
EBITDA Margin	-	-	-	-	-	20.54%	30.55%	22.32%	19.38%
Net Income	1.64B	2.13B	-1.40B	3.12B	4.00B	3.25B	4.58B	3.77B	2.59B
Net Income Margin	11.39%	12.96%	-7.58%	15.78%	14.72%	13.36%	21.23%	15.12%	10.83%
R&D	-	-	-	976.85M	1.18B	1.07B	837.00M	1.23B	1.35B
R&D as % of Total Revenue	-	-	-	4.94%	4.35%	4.40%	3.88%	4.94%	5.65%
Interest Expense	0	0	0	4.60M	5.76M	4.60M	4.60M	4.60M	8.91M
Interest Expense % of Total Revenue	0.00%	0.00%	0.00%	0.02%	0.02%	0.02%	0.02%	0.02%	0.04%

Balance Sheet

Currency: KRW	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	16.80B	19.80B	28.16B	31.07B	42.00B	43.07B	45.95B	51.64B	52.35B
Total Liabilities	7.88B	8.83B	2.47B	2.91B	10.39B	8.13B	3.90B	6.73B	5.42B
Total Equity	8.93B	10.97B	25.69B	28.16B	31.61B	34.95B	42.05B	44.91B	46.93B
Cash	3.95M	1.80M	2.04B	3.62B	1.58M	621.71K	3.31B	922.23K	3.40B
Total Debt	5.19B	2.44B	19.07M	364.37M	-	-	-	-	-
Net Debt	-	-	-	-	812.85M	2.00B	-	-	-

Cash Flow

Currency: KRW	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	1.38B	1.98B	3.05B	2.58B	3.09B	1.67B	9.47B	4.29B	7.34B
Investing Cash Flow	-731.78M	-1.34B	-9.17B	-396.97M	-8.08B	-1.85B	-6.03B	-2.02B	-
Financing Cash Flow	-326.14M	323.00M	5.53B	-566.87M	4.13B	-748.39M	-1.88B	-937.58M	-
Capital Expenditure	777.66M	840.93M	2.55B	872.46M	2.36B	2.29B	2.42B	5.12B	462.42M
Free Cash Flow	-	-	266.28M	1.71B	734.39M	-617.53M	7.05B	-826.14M	6.88B
Dividends Paid	165.00M	77.00M	74.38M	406.49M	606.11M	809.75M	835.63M	869.94M	652.45M
FCF to OCF	-	-	8.72%	66.19%	23.74%	-36.99%	74.41%	-19.26%	93.70%
Dividend Paid to FCF	-	-	27.93%	23.80%	82.53%	-131.13%	11.86%	-105.30%	9.49%

Earnings

Report Date	Sep 30, 2019	Dec 31, 2019	Mar 31, 2020	Jun 30, 2020	Sep 30, 2020	Dec 31, 2020	Mar 31, 2021	Jun 30, 2021	Sep 30, 2021	Dec 31, 2021	Mar 31, 2022	Jun 30, 2022	Sep 30, 2022	Dec 31, 2022	Mar 31, 2023	Jun 30, 2023	Sep 30, 2023	Dec 31, 2023	Mar 31, 2024	Jun 30, 2024	Sep 30, 2024	Dec 31, 2024	Mar 31, 2025	Jun 30, 2025	Sep 30, 2025	Dec 31, 2025	Mar 31, 2026	Jun 30, 2026
EPS Estimate	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EPS Actual	-429.30	136.26	77.43	40.85	120.57	146.31	103.16	130.17	117.27	116.71	132.22	105.93	167.79	-10.28	98.77	208.14	139.99	95.28	141.01	168.13	59.76	64.04	56.71	124.74	45.04	71.44	87.61	-20.83
Surprise	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Timing	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Key Statistics & Ratios

Market Cap23.66B

Enterprise Value5.26B

Trailing P/E0.00

Forward P/E0.00

Price / Sales1.02

Price / Book0.51

Revenue (TTM)23.26B

Gross Profit (TTM)5.99B

EBITDA3.22B

Profit Margin6.85%

Operating Margin-4.49%

Return on Equity3.44%

Return on Assets2.16%

Shares Outstanding8.70M

Shares Float6.27M

Beta0.31

Dividend Yield2.21%

Dividend Rate60.00

Payout Ratio32.74%

Dividends

20251×

60.00Dec 29, 2025

20241×

75.00Dec 27, 2024

20231×

100.00Dec 27, 2023

20221×

100.00Dec 28, 2022

20211×

99.50Dec 29, 2021

20201×

74.63Dec 29, 2020

20191×

49.75Dec 27, 2019

Stock Splits

Dec 28, 2022201:200